Sian Tovey - Concepedia

Author

Sian Tovey

Glasgow Royal Infirmary ORCID

Also Known As

S M Tovey, S Tovey, S. M. Tovey, S. Tovey, S.M. Tovey, Sian M Tovey, Sian M. Tovey, Sian Tovey, T. Davies, Tovey, Sian

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Glasgow Royal Infirmary University of Glasgow Western Infirmary Edinburgh Cancer Research University Hospital Crosshouse

About

Sian Tovey is an author at Glasgow Royal Infirmary specializing in medicine, breast cancer, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	597
2	Cell Biology	4	4	188
3	Public Health	1	1	12
4	Cellular Physiology	1	1	99
5	Immunology	1	1	270

Sian Tovey

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
AKT activation predicts outcome in breast cancer patients treated with tamoxifen Tove Kirkegaard, Caroline Witton, Liane M. McGlynn, The Journal of Pathology Breast OncologyTamoxifen TreatmentTamoxifen ResistanceBreast Cancer PatientsMedicine	2005	270
Observer variation in immunohistochemical analysis of protein expression, time for a change? Thomas Kirkegaard, Joanne Edwards, Sian Tovey, Histopathology	2006	235
The ERBB4/HER4 Intracellular Domain 4ICD Is a BH3-Only Protein Promoting Apoptosis of Breast Cancer Cells Anjali Naresh, Weiwen Long, Gregory A. Vidal, Cancer Research	2006	206
Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer? Sian Tovey, Barbara Dunne, Caroline Witton, Clinical Cancer Research	2005	140
Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling Sian Tovey, Caroline Witton, John M.S. Bartlett, Breast Cancer Research	2004	136
Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor–Positive Tumors of Tamoxifen-Treated Breast Cancer Patients Tove Kirkegaard, Liane M. McGlynn, Fiona Campbell, Clinical Cancer Research	2007	105
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours Sian Tovey, S. Brown, J. Doughty, British Journal of Cancer	2009	99
Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells Jaclyn S. Long, Joanne Edwards, Carol Watson, Molecular and Cellular Biology Induces ToleranceBreast OncologyCellular PhysiologyTumor BiologySk1 Expression	2010	99
Five-year follow-up of participants in a randomised controlled trial showing benefits from exercise for breast cancer survivors during adjuvant treatment. Are there lasting effects? Nanette Mutrie, Anna Campbell, Sarah Barry, Journal of Cancer Survivorship	2012	86
Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients Liane M. McGlynn, Tove Kirkegaard, Joanne Edwards, Clinical Cancer Research	2009	78

Page 1